Your browser is no longer supported. Please, upgrade your browser.
Settings
ESRX Express Scripts Holding Company daily Stock Chart
ESRX [NASD]
Express Scripts Holding Company
IndexS&P 500 P/E8.76 EPS (ttm)11.07 Insider Own0.45% Shs Outstand563.86M Perf Week-1.32%
Market Cap54.64B Forward P/E10.11 EPS next Y9.59 Insider Trans-1.10% Shs Float560.44M Perf Month1.68%
Income6.28B PEG0.72 EPS next Q2.67 Inst Own87.40% Short Float2.51% Perf Quarter10.30%
Sales101.35B P/S0.54 EPS this Y87.50% Inst Trans-0.12% Short Ratio3.68 Perf Half Y24.63%
Book/sh36.54 P/B2.65 EPS next Y5.47% ROA9.00% Target Price92.93 Perf Year56.44%
Cash/sh6.57 P/C14.74 EPS next 5Y12.23% ROE25.60% 52W Range60.63 - 100.43 Perf YTD29.82%
Dividend- P/FCF13.57 EPS past 5Y41.20% ROI19.00% 52W High-3.51% Beta0.87
Dividend %- Quick Ratio0.70 Sales past 5Y1.30% Gross Margin8.80% 52W Low59.82% ATR1.74
Employees26600 Current Ratio0.80 Sales Q/Q3.60% Oper. Margin5.30% RSI (14)51.43 Volatility1.70% 1.92%
OptionableYes Debt/Eq0.73 EPS Q/Q29.00% Profit Margin4.80% Rel Volume0.94 Prev Close96.90
ShortableYes LT Debt/Eq0.63 EarningsOct 31 AMC Payout0.00% Avg Volume3.83M Price96.90
Recom2.80 SMA200.16% SMA501.60% SMA20018.26% Volume0 Change0.00%
Sep-18-18Downgrade Credit Suisse Outperform → Neutral
Jul-20-18Downgrade Robert W. Baird Outperform → Neutral
Mar-12-18Upgrade Bernstein Underperform → Mkt Perform
Mar-08-18Initiated Barclays Equal Weight $84
Feb-27-18Resumed BofA/Merrill Underperform
Feb-01-18Downgrade Bernstein Mkt Perform → Underperform
Jan-31-18Upgrade RBC Capital Mkts Sector Perform → Outperform
Jan-05-18Initiated Evercore ISI In-line
Dec-15-17Upgrade Robert W. Baird Neutral → Outperform $72 → $81
Dec-14-17Reiterated Maxim Group Buy $78 → $87
Dec-06-17Upgrade Bernstein Underperform → Mkt Perform
Dec-04-17Initiated Deutsche Bank Buy $75
Oct-09-17Downgrade Raymond James Mkt Perform → Underperform
Sep-19-17Initiated RBC Capital Mkts Sector Perform $68
Jul-21-17Initiated Needham Hold
Apr-26-17Downgrade Edward Jones Buy → Hold
Apr-25-17Reiterated Mizuho Neutral $76 → $61
Mar-15-17Downgrade Wells Fargo Market Perform → Underperform
Nov-04-16Upgrade Deutsche Bank Sell → Hold $69 → $70
Aug-02-16Reiterated Mizuho Neutral $77 → $82
Nov-19-18 06:00AM  Petco and Express Scripts Team Up to Revolutionize Home Delivery of Pet Medicines PR Newswire
Nov-15-18 02:56PM  Capital Exchange: Express Scripts CEO on the intersection... CNBC Videos
08:30AM  Lower Drug Prices Get an Assist From a Big Player Bloomberg
Nov-13-18 08:53AM  Walmart, Home Depot adopt health insurer tactic in drug copay battle Reuters
07:01AM  Express Scripts Introduces Novel Formulary Built for Evolution of Drug Pricing PR Newswire
07:00AM  Express Scripts offers new formulary for lower list-price drugs Reuters
07:00AM  Walmart, Home Depot adopt health insurer tactic in drug copay battle Reuters
Nov-08-18 04:12PM  Jeff Auxier Comments on Express Scripts Holding GuruFocus.com
Nov-06-18 04:03PM  Express Scripts' myMatrixx Launches myDataSense Analytics Tool PR Newswire
Nov-05-18 07:52AM  The Zacks Analyst Blog Highlights: Verizon, Express Scripts, Cigna, Ecolab and eBay Zacks
07:28AM  'Centene effect': What impact the managed health care provider, Cortex are having on St. Louis office scene American City Business Journals
Nov-02-18 01:50PM  Top Stock Reports for Verizon, Express Scripts & Cigna Zacks
09:30AM  ESRX or HQY: Which Is the Better Value Stock Right Now? Zacks
09:15AM  Express Scripts (ESRX) Soars to 52-Week High, Time to Cash Out? Zacks
Nov-01-18 02:17PM  Cigna Corp (CI) Q3 2018 Earnings Conference Call Transcript Motley Fool
10:21AM  Cigna CEO on earnings and pending Express Scripts merger CNBC Videos
09:41AM  Improving Results for Express Scripts Morningstar
09:36AM  Stock Market News For Nov 1, 2018 Zacks
09:03AM  Cigna says Express Scripts deal to close by end of year Reuters
07:25AM  Express Scripts (ESRX) Tops Q3 Earnings & Revenue Estimates Zacks
01:06AM  Express Scripts Earnings, Revenue beat in Q3 Investing.com
Oct-31-18 05:30PM  Express Scripts (ESRX) Q3 Earnings and Revenues Surpass Estimates Zacks
05:05PM  ExpressScripts Stock Is Trading Flat Despite Earnings Beat InvestorPlace
04:21PM  Express Scripts: 3Q Earnings Snapshot Associated Press
04:11PM  Express Scripts Announces 2018 Third Quarter Results PR Newswire
10:58AM  Stocks - U.S. Futures Rise as Investors Turn to Earnings Results Investing.com
Oct-30-18 09:53AM  Healthcare Q3 Earnings to Watch on Oct 31: ANTM, MOH, ESRX Zacks
Oct-29-18 11:24AM  The bigger message behind Amgens decision to slash cost of its Repatha cholesterol drug MarketWatch
Oct-26-18 03:56PM  Which St. Louis public company is the largest by market cap? American City Business Journals
Oct-24-18 06:48PM  Amgen cuts U.S. price of cholesterol drug Repatha by 60 percent Reuters
04:24PM  How Express Scripts uses data to predict and prevent diabetes American City Business Journals
04:06PM  Amgen cuts price of cholesterol drug Repatha by 60 percent Reuters
04:01PM  Amgen cuts price of cholesterol drug by almost 60%, echoing rival's move CNBC
10:31AM  Express Scripts (ESRX) Q3 Earnings Preview: What to Watch Ahead of the Release Zacks
06:00AM  Express Scripts' Innovative Advanced Opioid Management Solution Shifts First-Time Opioid Users to Safer, Short-Term Prescriptions PR Newswire
Oct-23-18 03:23PM  How Express Scripts uses data to predict and prevent diabetes American City Business Journals
10:10AM  Can Express Scripts (ESRX) Keep the Earnings Surprise Streak Alive? Zacks
08:03AM  National Drug Purchasing Coalition - member companies include PepsiCo, Inc. and ExxonMobil - and Express Scripts Team Up to Create New Pharmacy Benefit Design for Greater Performance Accountability, Transparency, and Alignment PR Newswire
Oct-19-18 04:04PM  IBD Stock Of The Day Cigna Nears Buy Point After Fighting Off Merger Doubts Investor's Business Daily
Oct-17-18 01:59PM  Exclusive: Express Scripts covers Amgen, Lilly migraine drugs, excludes Teva Reuters
01:38PM  Express Scripts covers Amgen, Lilly migraine drugs, excludes Teva Reuters
09:00AM  Express Scripts Offers New Value-Based Program for Migraine PR Newswire
Oct-16-18 04:13PM  Express Scripts Holding Company Announces Third Quarter 2018 Earnings Release Details PR Newswire
Oct-15-18 08:59AM  What's in Store for Express Scripts' (ESRX) Q3 Earnings? Zacks
Oct-10-18 08:58AM  Express Scripts Introduces Medicare PDP Offerings for 2019 Zacks
08:57AM  Express Scripts' Stock Has a Prescription for Further Gains TheStreet.com
Oct-09-18 06:53PM  Cramer's lightning round: Buy Express Scripts on its upcoming merger CNBC
05:13PM  Express Scripts Readies Emergency Support for Impacted Members in Advance of Hurricane Michael PR Newswire
02:29PM  Express Scripts Readies Emergency Support for Impacted Members in Advance of Hurricane Michael PR Newswire
08:45AM  Express Scripts Introduces Medicare Part D Plan Offerings for 2019 PR Newswire
Oct-08-18 04:46PM  Express Scripts' Accredo & Akcea Tie Up to Distribute TEGSEDI Zacks
04:10PM  IBD Stock Of The Day Forms New Buy Point After 32% Run Investor's Business Daily
02:30PM  10 Stocks to Buy As They Soar Higher in Q4 and Beyond InvestorPlace
Oct-05-18 05:33PM  Akcea Announces Its Access and Distribution Strategy for TEGSEDI (inotersen) GlobeNewswire
Oct-03-18 08:08AM  Express Scripts Flattens the Trajectory of the Diabetes Epidemic with SafeGuardRx Diabetes Care Value® Program PR Newswire
Oct-02-18 10:17AM  Cigna Gets Merger Nod, Forms Management for Unified Entity Zacks
06:40AM  Hedge funds in the business of breaking up deals see big payoff, study finds CNBC
Oct-01-18 07:15PM  6 Predictable Stocks With Wide Margins of Safety GuruFocus.com
08:08AM  Inside Rx Announces Access to Fertility Services for Uninsured Americans with Freedom FP Fertility Pharmacy PR Newswire
Sep-28-18 04:35PM  Bull of the Day: Cigna (CI) Zacks
02:17PM  Aetna a Step Closer to CVS Merger, Sells Medicare Business Zacks
08:20AM  New Research Coverage Highlights Employers, Alliqua BioMedical, Express Scripts Holding, CF Industries, Nutanix, and Coca-Cola Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Sep-26-18 03:45PM  Gilead Is Undercutting Its Own Drugs: Here's Why Motley Fool
Sep-24-18 04:32PM  Gilead to launch generic versions of its hepatitis drugs Reuters
04:10PM  Gilead to Sell Cheaper Versions of Drug That Sparked Cost Debate Bloomberg
Sep-21-18 02:05PM  Halfmoon Parent, Inc. -- Moody's assigns a P-2 commercial paper rating to Halfmoon Parent, Inc. Moody's
Sep-19-18 03:00PM  Express Scripts Earns Highest Overall Customer Satisfaction Rating According to Independent Survey of Plan Sponsors PR Newswire
Sep-18-18 12:37PM  Department of Justice Approves Cigna-Express Scripts Deal GuruFocus.com
11:20AM  Cigna Moves Closer to Express Scripts Buyout With DoJ Nod Zacks
06:49AM  [$$] Stocks to Watch: FedEx, Oracle, Avon, Express Scripts The Wall Street Journal
12:36AM  PRESS DIGEST -Wall Street Journal - Sept 18 Reuters
Sep-17-18 06:09PM  Cigna deal gets antitrust nod, positive sign for CVS/Aetna Reuters
06:09PM  Cigna deal gets antitrust nod, positive sign for CVS-Aetna Reuters
05:31PM  Cigna-Express Scripts deal gets U.S. antitrust approval Reuters
05:22PM  Congratulations, Cigna! Now Comes the Hard Part. Bloomberg
03:04PM  Cigna-Express scripts deal gets anti-trust approval Reuters
02:59PM  Cigna-Express Scripts Deal Is Cleared by U.S. Justice Department Bloomberg
02:57PM  DOJ clears Cigna's acquisition of Express Scripts CNBC
Sep-12-18 02:19PM  Express Scripts Implements Emergency Procedures for Affected Members in Advance of Hurricane Florence PR Newswire
Sep-10-18 11:09AM  Why Express Scripts Gained 11% in August Motley Fool
Sep-06-18 05:00PM  Express Scripts Holding Company -- Moody's changes direction of Express Scripts rating review from uncertain to downgrade Moody's
04:02PM  IBD Stock Of The Day: This Health Leader Hits Buy Point After Tight Trading Investor's Business Daily
01:47PM  WellCare in talks to buy some CVS-Aetna assets, Wall Street Journal reports American City Business Journals
08:56AM  Cigna Is Selling Bonds to Finance Express Scripts Deal Bloomberg
Sep-05-18 08:04PM  [$$] Justice Department Nearing Antitrust Approval of Health Mergers Combining CVS-Aetna, Cigna-Express Scripts The Wall Street Journal
07:07PM  [$$] Justice Department Nearing Antitrust Approval of Health Mergers The Wall Street Journal
04:15PM  Major Health-Industry Deals Move Closer to Approval Bloomberg
02:21PM  Justice Department reportedly close to approving CVS-Aetna, Cigna-Express Scripts deals CNBC
09:00AM  Inside Rx® Prescription Savings Card Boosts Deep Discounts on Brand-Name Medications to more than 130 Drugs PR Newswire
Aug-31-18 04:11PM  5 Stocks With Low Price-Sales Ratios GuruFocus.com
09:55AM  Express Scripts (ESRX) Up 13.2% Since Last Earnings Report: Can It Continue? Zacks
Aug-24-18 08:19PM  [$$] Shareholders Approve Cigna-Express Scripts Deal The Wall Street Journal
01:56PM  Cigna, Express Scripts shareholders vote to approve merger CNBC
01:07PM  [$$] Shareholders Approve Cigna-Express Scripts Deal The Wall Street Journal
11:56AM  Cigna, Express Scripts shareholders vote for planned combo Associated Press
11:56AM  Cigna, Express Scripts shareholders approve $52 billion deal Reuters
10:53AM  Express Scripts Stockholders Approve Acquisition by Cigna PR Newswire
10:07AM  Cigna shareholders approve $52 bln Express Scripts acquisition Reuters
07:10AM  Yahoo Finance Live: Market Movers - Aug 24th, 2018 Yahoo Finance Video
Aug-21-18 08:47AM  Trump slams Fed chairman over interest rates Yahoo Finance
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services. This segment also provides Medicare, Medicaid, and health insurance marketplace products; Express Scripts SafeGuardRx, a suite of solutions targeting the therapy classes that pose clinical challenges and budgetary threat to its clients; and Inside Rx, a program that provide affordable access to medication for uninsured and underinsured individuals. Its Other Business Operations segment distributes specialty pharmaceuticals and medical supplies, including injectable and infusible pharmaceuticals and medications to treat specialty and rare/orphan diseases. This segment also provides medical benefit management solutions for radiology, cardiology, musculoskeletal disorders, sleep disorders, post-acute care, genetic lab, specialty pharmacy, and medical oncology. The company serves managed care organizations, health insurers, third-party administrators, employers, union-sponsored benefit plans, workers' compensation plans, government health programs, providers, clinics, hospitals, and others. As of December 31, 2017, it operated 4 automated dispensing home delivery pharmacies; 1 non-automated dispensing home delivery pharmacy; 7 non-dispensing order processing centers; 5 patient contact centers; 9 specialty home delivery pharmacies; and 34 specialty branch pharmacies. The company was formerly known as Aristotle Holding, Inc. and changed its name to Express Scripts Holding Company in April 2012. Express Scripts Holding Company was founded in 1986 and is headquartered in Saint Louis, Missouri.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MAC MAHON THOMAS PDirectorNov 07Sale99.505,234520,7930Nov 09 04:02 PM
DeLaney William J IIIDirectorOct 26Option Exercise46.705,464255,16917,696Oct 30 04:20 PM
Houston ChristineExecutive Vice PresidentAug 10Option Exercise53.0512,898684,239110,908Aug 14 04:33 PM
Houston ChristineExecutive Vice PresidentAug 10Sale85.0012,8981,096,33098,010Aug 14 04:33 PM
Houston ChristineExecutive Vice PresidentJun 13Option Exercise53.0510,000530,500108,010Jun 15 04:14 PM
Houston ChristineExecutive Vice PresidentJun 13Sale82.2810,000822,80098,010Jun 15 04:14 PM
Breen Maura CDirectorApr 27Option Exercise57.597,466429,96730,108May 01 04:17 PM
Mergenthaler FrankDirectorApr 26Option Exercise57.597,466429,96735,187Apr 30 04:32 PM
MAC MAHON THOMAS PDirectorApr 26Option Exercise57.597,466429,96762,044Apr 30 04:30 PM
LAHOWCHIC NICHOLASDirectorApr 26Option Exercise57.597,466429,96739,026Apr 30 04:26 PM
Houston ChristineExecutive Vice PresidentMar 15Option Exercise43.7719,889870,542117,899Mar 19 04:15 PM
Houston ChristineExecutive Vice PresidentMar 15Sale76.6919,8891,525,30798,010Mar 19 04:15 PM
Wade Sara ESr. VP and Ch. Human Res. Off.Mar 02Option Exercise56.5020,3481,149,66275,825Mar 06 04:29 PM
Paz GeorgeDirectorMar 02Option Exercise56.50161,6669,134,129980,826Mar 06 04:26 PM
Miller Steven BSr. VP & Chief Med. OfficerMar 02Option Exercise56.5020,3481,149,66264,343Mar 06 04:21 PM
Neville EverettExe VP, Strat, Sup Chn & SpcltMar 01Sale75.264,895368,39811,176Mar 02 04:40 PM
Wade Sara ESr. VP and Ch. Human Res. Off.Feb 22Option Exercise54.593,646199,03561,406Feb 26 04:09 PM
Stettin Glen D.Sr. VP, Clin. Res. & New Sol.Jan 11Sale81.003,449279,36933,715Jan 12 05:03 PM
Stettin Glen D.Sr. VP, Clin. Res. & New Sol.Jan 02Option Exercise75.2315811,88637,213Jan 04 04:06 PM
Stettin Glen D.Sr. VP, Clin. Res. & New Sol.Jan 02Sale76.003,448262,04837,055Jan 04 04:06 PM
Houston ChristineExecutive VP & COODec 15Option Exercise56.5010,104570,87687,400Dec 18 05:17 PM
Houston ChristineExecutive VP & COODec 15Sale70.0810,104708,04877,296Dec 18 05:17 PM